JP3390874B2 - Protein crystal growth method - Google Patents
Protein crystal growth methodInfo
- Publication number
- JP3390874B2 JP3390874B2 JP31803992A JP31803992A JP3390874B2 JP 3390874 B2 JP3390874 B2 JP 3390874B2 JP 31803992 A JP31803992 A JP 31803992A JP 31803992 A JP31803992 A JP 31803992A JP 3390874 B2 JP3390874 B2 JP 3390874B2
- Authority
- JP
- Japan
- Prior art keywords
- crystal
- protein
- precipitant
- concentration
- precipitating agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C30—CRYSTAL GROWTH
- C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
- C30B7/00—Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Crystallography & Structural Chemistry (AREA)
- Materials Engineering (AREA)
- Metallurgy (AREA)
- Organic Chemistry (AREA)
- Enzymes And Modification Thereof (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
- Peptides Or Proteins (AREA)
Description
【0001】[0001]
【産業上の利用分野】本発明は大型のタンパク質結晶を
成長させる方法に関し、さらに詳しくいえば、本発明は
結晶沈澱剤の濃度勾配を形成することにより大型のタン
パク質結晶を成長させる方法に関するものである。FIELD OF THE INVENTION The present invention relates to a method for growing large protein crystals, and more particularly to a method for growing large protein crystals by forming a concentration gradient of a crystal precipitant. is there.
【0002】[0002]
【従来の技術】インターフェロン、でんぷん糖化酵素な
どのタンパク質からなる医薬品の改良などのために遺伝
子操作が実施されるが、遺伝子操作を効果的に実施する
ためにはタンパク質の立体的な構造の情報が必要であ
る。タンパク質の立体的な構造を解析するためには、タ
ンパク質の結晶を形成しX線回折により解析することが
現時点での唯一の方法であり、X線回折による解析には
大型の単結晶が必要である。従来は、タンパク質を含む
溶液を入れた容器の底部に粉末の結晶沈澱剤を置き沈澱
剤が溶解して拡散することにより沈澱剤の濃度勾配を形
成し結晶を成長させていた(特公昭58−29958号
公報参照)。2. Description of the Related Art Genetic engineering is carried out in order to improve medicines composed of proteins such as interferon and starch saccharifying enzyme, but in order to carry out genetic engineering effectively, information on the three-dimensional structure of the protein is required. is necessary. To analyze the three-dimensional structure of a protein, the only method at present is to form a protein crystal and analyze it by X-ray diffraction. A large single crystal is required for analysis by X-ray diffraction. is there. Conventionally, a powdery crystal precipitant was placed at the bottom of a container containing a solution containing a protein, and the precipitant was dissolved and diffused to form a concentration gradient of the precipitant to grow crystals (Japanese Patent Publication No. 58- 29958).
【0003】[0003]
【発明が解決しようとする課題】塩化マグネシウム、塩
化カルシウムのような水に溶ける際に発熱する塩を結晶
沈澱剤として使用すると、タンパク質水溶液と塩の粉末
とが接触して塩が溶解する際に液温が上昇し、タンパク
質が変性してしまい大きな結晶ができなくなるという欠
点があった。従って、発熱を防いで結晶沈澱剤の濃度勾
配を形成する手段が必要となっていた。When a salt that generates heat when dissolved in water, such as magnesium chloride or calcium chloride, is used as a crystal precipitant, when the aqueous solution of protein and the powder of the salt come into contact with each other to dissolve the salt. There is a drawback that the liquid temperature rises and the protein is denatured and large crystals cannot be formed. Therefore, there has been a need for means for preventing heat generation and forming a concentration gradient of the crystal precipitating agent.
【0004】[0004]
【課題を解決するための手段】本発明は結晶沈澱剤を含
む溶液にタンパク質を含む溶液を静かに重層し、結晶沈
澱剤が高濃度領域から低濃度領域に拡散することにより
結晶沈澱剤の濃度勾配を形成し、その至適濃度領域にお
いてタンパク質結晶を成長させることを特徴とするタン
パク質結晶の成長方法である。According to the present invention, a solution containing a protein is gently layered on a solution containing a crystal precipitating agent, and the crystal precipitating agent is diffused from a high concentration region to a low concentration region, whereby the concentration of the crystal precipitant is increased. A method for growing a protein crystal, which comprises forming a gradient and growing the protein crystal in the optimum concentration region.
【0005】本発明では結晶沈澱剤の粉末を容器の底部
に置く変わりに、先ず結晶沈澱剤を含む溶液を容器に入
れ、これにタンパク質を含む溶液を静かに重層すること
により結晶沈澱剤を容器の一方に局在させる。結晶沈澱
剤は拡散によりタンパク質を含む溶液に拡がり濃度勾配
を形成する。この方法では塩化マグネシウムのような水
溶液に溶解する際に発熱する結晶沈澱剤をあらかじめ液
に完全に溶解させ、溶解による発熱が収まってから結晶
成長させる温度に冷却してタンパク質を含む溶液と接触
させるので、熱によるタンパク質の変性を防止できる。In the present invention, instead of placing the powder of the crystal precipitating agent at the bottom of the container, first, the solution containing the crystal precipitating agent is placed in the container, and the solution containing the protein is gently overlaid on the container to add the crystal precipitating agent to the container. Localize on one side. The crystal precipitant spreads to the protein-containing solution by diffusion and forms a concentration gradient. In this method, a crystal precipitating agent that generates heat when dissolved in an aqueous solution such as magnesium chloride is completely dissolved in advance in the solution, and then cooled to a temperature for crystal growth after contact with the solution containing protein after the heat generated by the dissolution has subsided. Therefore, denaturation of protein due to heat can be prevented.
【0006】[0006]
【作用】結晶沈澱剤がタンパク質と接触する前の段階で
少量の液に溶かす。この時、結晶沈澱剤によっては発熱
するものもある。発熱する場合は結晶成長に適した温度
になるまで冷却する。次に結晶沈澱剤を含む溶液を容器
に入れ、これにタンパク質を含む溶液を静かに重層す
る。溶解する際に発熱する結晶沈澱剤であっても、この
段階では既に溶解過程を過ぎているので、タンパク質を
含む溶液と接触しても発熱することはないのでタンパク
質は熱により変性しない。結晶沈澱剤は拡散により順次
上方に向けて希釈された濃度を形成させることにより濃
度勾配を与える。Function: The crystal precipitant is dissolved in a small amount of liquid before contact with the protein. At this time, some crystal precipitants generate heat. When it generates heat, it is cooled to a temperature suitable for crystal growth. Next, the solution containing the crystal precipitant is placed in a container, and the solution containing the protein is gently overlaid thereon. Even a crystal precipitating agent that generates heat when dissolved does not generate heat even when it comes into contact with a solution containing a protein because the dissolution process has already passed at this stage, so the protein is not denatured by heat. The crystallizing precipitant provides a concentration gradient by forming upwardly diluted concentrations by diffusion.
【0007】一般に、タンパク質の溶解度Sと結晶沈澱
剤濃度γとの間には次式に示す関係がある。
logS=logSo −Kγ
ここでSo ,Kは定数である。タンパク質の結晶は初期
タンパク質濃度が溶解度をわずかに超える辺りで大きく
成長するので、容器内のタンパク質濃度が一定でかつ塩
濃度勾配が形成されているならば、容器内の特定の箇所
に結晶成長に至適な結晶沈澱剤濃度が現れる。従って、
該箇所で結晶が成長する。Generally, there is a relationship between the protein solubility S and the crystal precipitating agent concentration γ as shown in the following equation. logS = logSo-Kγ where So and K are constants. Since protein crystals grow greatly when the initial protein concentration slightly exceeds the solubility, if the protein concentration in the container is constant and a salt concentration gradient is formed, crystal growth will occur at a specific point in the container. The optimum crystal precipitant concentration appears. Therefore,
A crystal grows at this point.
【0008】[0008]
【実施例】塩化マグネシウム1.0gを内径13mmの
試験管に入れ、これに蒸留水3.0ミリリットルを加え
てよく攪拌して溶かし、室温(約20℃)まで冷却し
た。これとは別に結晶を作成するタンパク質である卵白
リゾチーム0.5gを蒸留水7.0ミリリットルに溶か
し、塩酸によりpH4.65に調整した。この卵白リゾ
チーム溶液を塩化マグネシウム溶液の入った試験管に添
加した。この際、塩化マグネシウム溶液と卵白リゾチー
ム溶液との界面が乱れることのないよう静かに重層し
た。[Examples] 1.0 g of magnesium chloride was placed in a test tube having an inner diameter of 13 mm, 3.0 ml of distilled water was added thereto, and the mixture was thoroughly stirred to dissolve it, and cooled to room temperature (about 20 ° C). Separately, 0.5 g of egg white lysozyme, which is a protein for forming crystals, was dissolved in 7.0 ml of distilled water, and the pH was adjusted to 4.65 with hydrochloric acid. This egg white lysozyme solution was added to a test tube containing a magnesium chloride solution. At this time, the layers were gently overlaid so that the interface between the magnesium chloride solution and the egg white lysozyme solution was not disturbed.
【0009】次に試験管にシリコン栓をして23℃に保
った恒温装置に静置した。時間の経過とともに塩化マグ
ネシウム分子が上方に拡散し、塩化マグネシウムの濃度
が下方から上方に向かって次第に薄くなる濃度勾配が形
成された。下から48mmの位置に最も大きな結晶が成
長し、21日後に1.4×1.4×2.9mmとなっ
た。この結晶の成長曲線を図1に示す。Next, the test tube was capped with a silicone and allowed to stand in a thermostat kept at 23 ° C. Over time, magnesium chloride molecules diffused upward, and a concentration gradient was formed in which the concentration of magnesium chloride gradually decreased from the lower side to the upper side. The largest crystal grew at a position 48 mm from the bottom, and after 21 days, the size was 1.4 × 1.4 × 2.9 mm. The growth curve of this crystal is shown in FIG.
【0010】[0010]
【発明の効果】塩化マグネシウムは水に溶ける際に発熱
する。従来の方法ではタンパク質溶液と塩化マグネシウ
ムの粉末とを接触させると溶解する過程で発熱するの
で、タンパク質が変性してしまい結晶が大きくならなか
った。本発明のように、事前に結晶沈澱剤を液に溶解す
ればタンパク質が溶解時の発熱にさらされることがなく
なり、タンパク質が熱により変性することがなくなるの
で、溶解時に発熱する結晶沈澱剤にも濃度勾配法を適用
することができるようになった。よって、タンパク質や
酵素を対象とする各種工業に好適に利用することができ
る。EFFECT OF THE INVENTION Magnesium chloride generates heat when dissolved in water. In the conventional method, when the protein solution and the magnesium chloride powder were brought into contact with each other, heat was generated in the process of dissolution, so that the protein was denatured and the crystals did not grow. As in the present invention, if the crystal precipitating agent is dissolved in a liquid in advance, the protein will not be exposed to the heat of dissolution and the protein will not be denatured by heat. It became possible to apply the concentration gradient method. Therefore, it can be suitably used for various industries targeting proteins and enzymes.
【図1】本発明の実施例に係るタンパク質として卵白リ
ゾチームを、結晶沈澱剤として塩化マグネシウムを使用
した場合の結晶成長曲線を示す図表。FIG. 1 is a diagram showing a crystal growth curve when egg white lysozyme is used as a protein and magnesium chloride is used as a crystal precipitant according to an example of the present invention.
───────────────────────────────────────────────────── フロントページの続き (56)参考文献 特開 平1−308897(JP,A) 特開 昭64−56400(JP,A) 特開 昭63−282186(JP,A) 特開 昭53−109554(JP,A) (58)調査した分野(Int.Cl.7,DB名) C07K 1/02 C30B 7/00 C30B 29/54 JICSTファイル(JOIS)─────────────────────────────────────────────────── --Continued from the front page (56) References JP-A-1-308897 (JP, A) JP-A 64-56400 (JP, A) JP-A 63-282186 (JP, A) JP-A 53- 109554 (JP, A) (58) Fields surveyed (Int.Cl. 7 , DB name) C07K 1/02 C30B 7/00 C30B 29/54 JISST file (JOIS)
Claims (2)
た後、結晶成長させる温度に冷却した結晶沈殿剤の濃厚
水溶液の上にタンパク質を含む水溶液を静かに重層し、
結晶沈殿剤が高濃度領域から低濃度領域に拡散すること
により結晶沈殿剤の濃度勾配を形成し、その至適濃度領
域においてタンパク質結晶を成長させる方法。1. A crystal precipitating agent is previously dissolved in water to generate heat.
After that, the concentration of the crystal precipitant cooled to the temperature for crystal growth
Gently overlaid with an aqueous solution containing the protein on top of the aqueous solution,
A method of growing a protein crystal in the optimum concentration region by forming a concentration gradient of the crystal precipitant by diffusing the crystal precipitant from a high concentration region to a low concentration region.
求項1に記載したタンパク質結晶を成長させる方法。 2. The crystal precipitating agent is magnesium chloride.
A method for growing a protein crystal according to claim 1.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP31803992A JP3390874B2 (en) | 1992-11-27 | 1992-11-27 | Protein crystal growth method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP31803992A JP3390874B2 (en) | 1992-11-27 | 1992-11-27 | Protein crystal growth method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH06157598A JPH06157598A (en) | 1994-06-03 |
| JP3390874B2 true JP3390874B2 (en) | 2003-03-31 |
Family
ID=18094816
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP31803992A Expired - Lifetime JP3390874B2 (en) | 1992-11-27 | 1992-11-27 | Protein crystal growth method |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP3390874B2 (en) |
-
1992
- 1992-11-27 JP JP31803992A patent/JP3390874B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JPH06157598A (en) | 1994-06-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Levashov et al. | Enzymes entrapped into reversed micelles in organic solvents: Sedimentation analysis of the protein—aerosol OT-H2O-Octane system | |
| Giegé et al. | The role of purification in the crystallization of proteins and nucleic acids | |
| Luisi | Enzymes hosted in reverse micelles in hydrocarbon solution | |
| Gilliland | A biological macromolecule crystallization database: a basis for a crystallization strategy | |
| Wolbert et al. | Protein transfer from an aqueous phase into reversed micelles: the effect of protein size and charge distribution | |
| Leser et al. | Application of reverse micelles for the extraction of proteins | |
| FR2619567A1 (en) | HUMAN SERUM-ALBUMIN CRYSTALS AND PROCESS FOR THEIR PREPARATION | |
| Christopher et al. | Temperature-dependent solubility of selected proteins | |
| WO1983003054A1 (en) | A proces for producing an insulin preparation | |
| DE69004101D1 (en) | METHOD FOR CRYSTALLIZING ENZYMS. | |
| JP3390874B2 (en) | Protein crystal growth method | |
| JPH03259928A (en) | Production of highly polymeric gelatin | |
| Littlechild | Protein crystallization: magical or logical: can we establish some general rules? | |
| JPS62503036A (en) | Method for preparing gamma globulin administered intravenously and gamma globulin obtained by the method | |
| Iyengar | Photo-elastic dispersion in cubic crystals | |
| JPS5829958B2 (en) | How to form protein crystals | |
| JPH0160235B2 (en) | ||
| Garber et al. | Crystals of seryl-tRNA synthetase from Thermus thermophilus: Preliminary crystallographic data | |
| NL192290C (en) | Stabilized solution of rennet. | |
| Bernard et al. | A gel-mediated feeding technique for protein crystal growth from hanging drops | |
| JP2712427B2 (en) | Method for stopping crystal growth of biopolymer | |
| Suzuki et al. | Hybridization of glyceraldehyde-3-phosphate dehydrogenase in borate | |
| HAYASHI et al. | Time-dependent Increase in Stability of Collagen Fibrils Formed in Vitro Effect of Temperature | |
| JPH08238069A (en) | Stabilized semifluid gelatinous seasoning put in container | |
| JPH0678783A (en) | Production of protein gel product |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EXPY | Cancellation because of completion of term |